Novartis
NVS
#57
Rank
โ‚ฌ198.09 B
Marketcap
97,87ย โ‚ฌ
Share price
-0.33%
Change (1 day)
12.94%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Revenue for Novartis (NVS)

Revenue in 2024 (TTM): โ‚ฌ45.67 Billion

According to Novartis's latest financial reports the company's current revenue (TTM ) is โ‚ฌ47.42 Billion. In 2023 the company made a revenue of โ‚ฌ42.20 Billion a decrease over the revenue in the year 2022 that were of โ‚ฌ46.39 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Novartis from 2000 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ45.67 B8.21%
2023 โ‚ฌ42.20 B-9.03%
2022 โ‚ฌ46.39 B-0.63%
2021 โ‚ฌ46.69 B15.09%
2020 โ‚ฌ40.56 B-6.64%
2019 โ‚ฌ43.45 B3.85%
2018 โ‚ฌ41.84 B0.14%
2017 โ‚ฌ41.78 B-11.1%
2016 โ‚ฌ46.99 B1.99%
2015 โ‚ฌ46.08 B4.5%
2014 โ‚ฌ44.09 B9.23%
2013 โ‚ฌ40.37 B-7.22%
2012 โ‚ฌ43.51 B-4.82%
2011 โ‚ฌ45.72 B17.95%
2010 โ‚ฌ38.76 B23.13%
2009 โ‚ฌ31.48 B3.35%
2008 โ‚ฌ30.46 B14.74%
2007 โ‚ฌ26.54 B0.08%
2006 โ‚ฌ26.52 B-3.17%
2005 โ‚ฌ27.39 B31.56%
2004 โ‚ฌ20.82 B5.44%
2003 โ‚ฌ19.74 B-11.47%
2002 โ‚ฌ22.30 B1.22%
2001 โ‚ฌ22.04 B-0.26%
2000 โ‚ฌ22.09 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ59.33 B 25.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ52.84 B 11.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ83.28 B 75.60%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ50.81 B 7.14%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ38.22 B-19.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ15.46 B-67.38%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚ฌ45.04 B-5.02%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ39.14 B-17.47%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ46.65 B-1.62%๐Ÿ‡ฌ๐Ÿ‡ง UK